Treatment for Tinea Capitis

Diagnostic Considerations

Pain with combing suggests inflammatory scalp infection, such as kerion formation, rather than simple seborrheic dermatitis, according to the British Association of Dermatologists 1
Failure to respond to ketoconazole shampoo strongly indicates tinea capitis, as topical therapy alone cannot penetrate hair shafts where dermatophytes reside, as stated by the British Journal of Dermatology 1, 2
Scaling with pain in a patient warrants immediate evaluation for fungal infection requiring systemic treatment, as recommended by the British Association of Dermatologists 1

The British Association of Dermatologists recommends oral systemic antifungal therapy, such as griseofulvin, as first-line treatment for tinea capitis, with a dosing of 20-25 mg/kg daily (or up to 1000 mg daily in adults) taken with fatty food for 6-8 weeks minimum 1
Terbinafine is an alternative treatment option, with a dosing of 250 mg daily for adults, and is more effective than griseofulvin for Trichophyton species, as reported by the British Journal of Dermatology 1
Adjunctive topical therapy with antifungal shampoo, such as ketoconazole 2% shampoo, selenium sulfide 1%, or povidone-iodine shampoo, 2-3 times weekly, is recommended to reduce spore transmission, as suggested by the British Association of Dermatologists 1, 2

The British Association of Dermatologists advises against using ketoconazole shampoo as monotherapy for tinea capitis, as it leads to treatment failure and potential permanent scarring alopecia 2
It is essential to distinguish tinea capitis from seborrheic dermatitis, as pain with combing is atypical for seborrheic dermatitis and suggests deeper follicular infection, as noted by the British Journal of Dermatology 1
Oral ketoconazole should not be used due to its significant hepatotoxicity risk and suboptimal efficacy compared to griseofulvin or terbinafine, as warned by the British Association of Dermatologists 2

The British Association of Dermatologists recommends clinical assessment every 2-4 weeks to evaluate response, with repeat fungal culture if no improvement after 4-6 weeks to assess for resistance or alternative diagnosis 1
Treatment should be continued for 2-4 weeks after complete clinical resolution to prevent relapse, as advised by the British Association of Dermatologists 1